Piper Sandler Upgrades Halozyme Therapeutics (HALO) to Overweight

May 10, 2023 3:38 AM EDT Send to a Friend
Piper Sandler analyst Joseph Catanzaro upgraded Halozyme Therapeutics (NASDAQ: HALO) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login